- $12.22m
- $38.24m
- $1.02m
Brief: U.S. Defense Dpartment To Study Pluristem's PLX-R18 For Treatment Of Mustard Gas Injuries
U.S. STOCKS ON THE MOVE-Twitter, Tesla, Galmed, RH
U.S. STOCKS ON THE MOVE-Naked Brand, Galmed, Tesla, Idera
U.S. STOCKS ON THE MOVE-Naked Brand, Pluristem, Ballard Power
Israel's Pluristem sees positive results from leg pain study
Pluristem Therapeutics: Surges on positive leg pain treatment data
Brief: Pluristem Reports Positive Top-Line Results From Its Multinational Phase II Intermittent Claudication Study
Brief: Pluristem Reports As Of March 31, Co Had $34.1 Mln In Cash And Cash Equivalents
U.S. STOCKS ON THE MOVE-Andeavor, First Data, Sprint, Cooper Tire, McDonald's
U.S. STOCKS ON THE MOVE-Sprint, Andeavor, Jumei, Cooper Tire, SteadyMed
FDA clears Pluristem radiation treatment for emergency use
U.S. STOCKS ON THE MOVE-H&R Block, TripAdvisor, Twitter, GE, Comcast
U.S. STOCKS ON THE MOVE-GE, Twitter, Norfolk Southern, Teradyne
U.S. STOCKS ON THE MOVE-Twitter, Lockheed, Boeing, Teradyne, Comcast
U.S. STOCKS ON THE MOVE-Twitter, Boeing, Teradyne, Comcast, Edward Lifesciences
U.S. STOCKS ON THE MOVE-Boeing, Teradyne, Comcast, MannKind, Edwards Lifesciences
U.S. STOCKS ON THE MOVE-Clorox, McDermott, Teradyne, Edwards Lifesciences, Vicor
Pluristem Therapeutics: Gets FDA nod to begin late-stage study of muscle treatment
Brief: U.S. FDA Clears Pluristem’S Phase III Study In Treatment Of Muscle Injury Following Hip Fracture Surgery